These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4149420)

  • 21. Definition and implications of dose-dependent kinetics in clinical medicine.
    Holtzman JL
    Drug Metab Rev; 1983; 14(6):1103-17. PubMed ID: 6426917
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of chronic heat exposure on drug metabolism in the rat.
    Ben Zvi Z; Kaplanski J
    J Pharm Pharmacol; 1980 May; 32(5):368-9. PubMed ID: 6104708
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of dietary energy and protein deficiency on drug metabolism.
    Hamberg O; Ovesen L; Dorfeldt A; Loft S; Sonne J
    Eur J Clin Pharmacol; 1990; 38(6):567-70. PubMed ID: 2373130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
    van Peer AP; Belpaire FM; Bogaert MG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):346-7. PubMed ID: 708161
    [No Abstract]   [Full Text] [Related]  

  • 25. Application of clearance concepts to some literature data on drug metabolism in the isolated perfused liver preparation and in vivo.
    Rowland M
    Eur J Pharmacol; 1972 Mar; 17(3):352-6. PubMed ID: 5022150
    [No Abstract]   [Full Text] [Related]  

  • 26. Practical pharmacokinetic techniques for drug consultation and evaluation. 3. Psychotherapeutic drugs as prototypes for illustrating some considerations in pharmacist-generated dosage regimens.
    Schumacher GE; Weiner J
    Am J Hosp Pharm; 1974 Jan; 31(1):59-66. PubMed ID: 4810166
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutic drug monitoring. Pharmacokinetics.
    Taylor WJ
    Am J Med Technol; 1983 Aug; 49(8):557-63. PubMed ID: 6670671
    [No Abstract]   [Full Text] [Related]  

  • 28. Dose-dependent pharmacokinetics of antipyrine in the rat.
    Pollack GM; Li RC; Shen DD
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):69-81. PubMed ID: 6729251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphic drug oxidation in humans.
    Eichelbaum M
    Fed Proc; 1984 May; 43(8):2298-302. PubMed ID: 6714436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Harmatz JS; Shader RI
    J Pharmacol Exp Ther; 1982 Jan; 220(1):120-6. PubMed ID: 7053408
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparative study of drug metabolism in the isolated perfused liver and in vivo in rats.
    von Bahr C; Alexanderson B; Azarnoff DL; Sjoqvist F; Orrenius S
    Eur J Pharmacol; 1970 Jan; 9(1):99-105. PubMed ID: 5434299
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of tricyclic antidepressants on drug metabolism.
    Pond SM; Graham GG; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1975 Aug; 18(2):191-9. PubMed ID: 50160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of the relation between pharmacokinetic processes and pharmacological effects in humans].
    Dorokhov VV; Kholodov LE
    Farmakol Toksikol; 1985; 48(5):119-25. PubMed ID: 3908140
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of combined pre-treatment on the metabolism of antipyrine in the rat.
    Szabó I; Renczes G; Gachályi B
    Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interindividual variations in drug disposition. Clinical implications and methods of investigation.
    Breimer DD
    Clin Pharmacokinet; 1983; 8(5):371-7. PubMed ID: 6627809
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of drug metabolism. VII. Differences in P-420 hemoproteins from untreated and 3-methylcholanthrene-treated rats.
    Shoeman DW; Vane FM; Mannering GJ
    Mol Pharmacol; 1973 May; 9(3):373-82. PubMed ID: 4710137
    [No Abstract]   [Full Text] [Related]  

  • 37. Dose-dependent pharmacokinetics: emphasis on phase I metabolism.
    Dayton PG; Sanders JE
    Drug Metab Rev; 1983; 14(3):347-405. PubMed ID: 6347591
    [No Abstract]   [Full Text] [Related]  

  • 38. Ascorbic acid and drug metabolism in cynomologus monkeys.
    Green M; Turnbull J; Sauberlich H; Omaye S
    Proc West Pharmacol Soc; 1978; 21():341-4. PubMed ID: 99749
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential dangers of common drug dosing regimens.
    Niebergall PJ; Sugita ET; Schnaare RL
    Am J Hosp Pharm; 1974 Jan; 31(1):53-8. PubMed ID: 4810165
    [No Abstract]   [Full Text] [Related]  

  • 40. [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
    Eichelbaum M
    Internist (Berl); 1983 Mar; 24(3):117-27. PubMed ID: 6135670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.